Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCvc Ig Eur Regulatory News (CVCE)

Share Price Information for Cvc Ig Eur (CVCE)

Share Price is delayed by 15 minutes
Get Live Data
1.055    0.00 (0.00%)
Bid:
1.05
Ask:
1.07
Spread: 0.02 (1.905%)
Market Cap: €292.81m
CVCE Live PriceLast checked at - London Stock Exchange

Intraday Cvc Ig Eur Share Chart

DIVIDEND DECLARATION & DIV TARGET '25(Replacement)

27 Jan 2025 18:15

RNS Number : 8572U
CVC Income & Growth Limited
27 January 2025
 

27 January 2025

 

CVC Income & Growth Limited

 

DIVIDEND DECLARATION & ANNUAL DIVIDEND TARGET '25 (Replacement)

 

The following amendment has been made to the announcement released on 24 January 2025 at 12:53hrs (RNS No. 6613U). In the second paragraph, the quarterly interim dividend per ordinary Euro share has been corrected from 2.486c to 2.0486c. All other details remain unchanged. The full amended text is shown below.

Dividend Declaration and

Annual Dividend Targets for financial year 2025

The information contained within this announcement constitutes inside information.

The Board of Directors of the Company has declared a quarterly interim dividend of 3.3038p per ordinary Sterling Share and 2.0486c per ordinary Euro Share.

These amounts reflect an uplift to the previously indicated quarterly dividend of 2.0625p per Sterling ordinary share and 1.8125c per Euro ordinary share announced by the Company on 30 January 2024.

The ex-dividend date will be 6 February 2025, with the dividends payable on 28 February 2025.

The Board of Directors, in conjunction with the Investment Vehicle Manager, has also completed its periodic review of the Company's annual dividend targets. As a consequence, the Company's annual dividend targets are 9.25p per ordinary Sterling Share (an increase of 1p above 2024) and 7.25c per ordinary Euro Share (unchanged from 2024) with from the first 2025 quarterly interim dividend. This means that the Company's quarterly dividends will be 2.3125p per Sterling Share and 1.8125c per Euro Share, including the Company's first quarter 2025 dividends, payable in the second quarter of 2025.

The Chairman of the Company, Robert Kirkby commented: "The Board of Directors continues to give detailed consideration, not only to the current cash yield of the Investment Vehicle's underlying portfolio by principal reference to its weighted average coupon, but also to market conditions including future trends in default rates and the direction of risk-free rates in the Investment Vehicle's chosen markets, given the Investment Vehicle's predominantly floating rate exposure. The Board is mindful that shareholders expect changes to dividend targets to be made on a sustainable basis, and thus, in the absence of significant and relevant unexpected macroeconomic or geopolitical events, the Company's annual dividend targets should not be changed for at least the next 12 months."

Mr Kirkby added "The Board of Directors also wishes to reconfirm that, in the event that the Investment Vehicle portfolio produces surplus cash income beyond that currently anticipated, an upwards only adjustment will, if appropriate, be made to the Company's fourth quarter 2025 dividends payable in the first quarter of 2026, in a manner similar to that recently announced in respect of the fourth quarter of 2024. There should be no expectation as to the level of any such adjustments or indeed whether such adjustments will arise at all."

The person responsible for arranging for the release of this announcement on behalf of the Company is Sharon A Williams of BNP Paribas S.A., Jersey Branch, Company Secretary.

 

Enquiries:

CVC Income & Growth Limited: +44 (0)1534 815200

Robert Kirkby

BNP Paribas S.A., Jersey Branch: cvcpeolcosec@bnpparibas.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVEAPFXAFFSEFA
Date   Source Headline
27th Sep 20242:22 pmRNSDirector/PDMR Shareholding
27th Sep 20247:00 amRNS2024 Half Yearly Financial Report
26th Sep 20244:20 pmRNSNet Asset Value Weekly to 20 Sep 2024
19th Sep 20243:15 pmRNSNet Asset Value Weekly to 13 Sep 2024
19th Sep 20241:59 pmRNSMonthly Report
16th Sep 20244:39 pmRNSNet Asset Value Month End 30 Aug 2024
12th Sep 20244:00 pmRNSNet Asset Value Weekly to 06 Sep 2024
5th Sep 20246:00 pmRNSNet Asset Value Weekly to 30 Aug 2024
5th Sep 202412:00 pmRNSResults of Placing for September 2024 Tender
30th Aug 202410:10 amRNSNet Asset Value Weekly to 23 Aug 2024
23rd Aug 20249:00 amRNSResult of Sept 24 Tender Process (Replacement)
22nd Aug 20243:45 pmRNSNet Asset Value Weekly to 16 Aug 2024
22nd Aug 20249:07 amRNSMonthly Report
16th Aug 202410:00 amRNSResult of Sept 2024 Semi-Annual Tender Process
15th Aug 20245:00 pmRNSNet Asset Value Weekly to 09 Aug 2024
15th Aug 202411:46 amRNSNet Asset Value Month End 31 Jul 2024
8th Aug 20244:50 pmRNSNet Asset Value Weekly to 02 Aug 2024
8th Aug 20249:05 amRNSDirector/PDMR Shareholding
1st Aug 20245:55 pmRNSNet Asset Value Weekly to 26 Jul 2024
1st Aug 20249:13 amRNSTotal Voting Rights
31st Jul 20247:00 amRNSDividend Declaration
30th Jul 202411:45 amRNSIssue of Equity
26th Jul 20244:18 pmRNSDirector/PDMR Shareholding
25th Jul 202410:39 amRNSIssue of Equity
25th Jul 202410:30 amRNSNet Asset Value Weekly to 19 Jul 2024
24th Jul 202412:08 pmRNSIssue of Equity
23rd Jul 20244:49 pmRNSIssue of Equity
23rd Jul 202412:36 pmRNSJuly 2024 Share Conversion
23rd Jul 20249:43 amRNSDirector Declaration
18th Jul 20243:00 pmRNSNet Asset Value Weekly to 12 Jul 2024
18th Jul 202410:06 amRNSMonthly Report
12th Jul 20245:00 pmRNSNet Asset Value Weekly to 05 Jul 2024
12th Jul 20242:53 pmRNSNet Asset Value Month End 28 Jun 2024
5th Jul 20249:06 amRNSSept Tender Restrictions
4th Jul 20244:00 pmRNSNet Asset Value Weekly to 28 Jun 2024
27th Jun 20244:20 pmRNSNet Asset Value Weekly to 21 Jun 2024
27th Jun 20242:53 pmRNSUK Reporting Fund Status
24th Jun 20247:00 amRNSFund Research Report
20th Jun 20244:00 pmRNSNet Asset Value Weekly to 14 Jun 2024
19th Jun 20249:27 amRNSMonthly Report
17th Jun 20249:58 amRNSJuly 2024 Share Conversion Request
14th Jun 20244:06 pmRNSNet Asset Value Month End 31 May 2024
13th Jun 20245:30 pmRNSNet Asset Value Weekly to 07 Jun 2024
6th Jun 20245:00 pmRNSNet Asset Value Weekly to 31 May 2024
3rd Jun 20244:18 pmRNSTotal Voting Rights
30th May 202412:45 pmRNSNet Asset Value Weekly to 24 May 2024
23rd May 20245:15 pmRNSNet Asset Value Weekly to 17 May 2024
21st May 20249:37 amRNSMonthly Report
20th May 20241:34 pmRNSDirector Declaration
17th May 20246:07 pmRNSNet Asset Value Month End 30 Apr 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.